News
-
-
PRESS RELEASE
Viromed Medical AG: Revolutionary cold plasma therapy for the treatment of ventilator-associated pneumonia (VAP) shows 100% efficacy in an in vitro study with MRSA and human lung cells (alveoli)
Viromed Medical AG announces groundbreaking results with cold plasma therapy for ventilator-associated pneumonia (VAP) in an in vitro study. Findings show 100% efficacy against MRSA bacteria without lung cell damage -
-
PRESS RELEASE
Exclusive contract for ViroCAP® My Plasma with Landsberg First Class Aesthetic opens up Viromed's entry into the European cosmetics market
Viromed Medical AG partners with Landsberg First Class Aesthetic to introduce ViroCAP® My Plasma into the European cosmetics market, enhancing aesthetic treatments with cold plasma technology -
-
-
-
PRESS RELEASE
Viromed Medical AG: Exclusive distribution partnership with AMAMUS Vet for the cold plasma medical device ViroCAP® VET for veterinary use
Viromed Medical AG partners with Lang Life Sciences GmbH's AMAMUS Vet for exclusive distribution of ViroCAP® VET cold plasma medical device for veterinary use in Germany, Austria, and Switzerland -
-
PRESS RELEASE
Viromed Medical AG: UMECO Group acquires exclusive marketing rights in Asia for cold plasma medical devices ViroCAP® and PulmoPlas®
Viromed Medical AG partners with UMECO Group for exclusive marketing rights of ViroCAP® and PulmoPlas® cold plasma medical devices in Asia, aiming to expand their reach in ten countries
